These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

570 related items for PubMed ID: 26699616

  • 1. Molecular modeling studies on series of Btk inhibitors using docking, structure-based 3D-QSAR and molecular dynamics simulation: a combined approach.
    Balasubramanian PK, Balupuri A, Cho SJ.
    Arch Pharm Res; 2016 Mar; 39(3):328-39. PubMed ID: 26699616
    [Abstract] [Full Text] [Related]

  • 2. Receptor-guided 3D-QSAR studies, molecular dynamics simulation and free energy calculations of Btk kinase inhibitors.
    Balasubramanian PK, Balupuri A, Kang HY, Cho SJ.
    BMC Syst Biol; 2017 Mar 14; 11(Suppl 2):6. PubMed ID: 28361711
    [Abstract] [Full Text] [Related]

  • 3. Exploration of Novel Inhibitors for Bruton's Tyrosine Kinase by 3D QSAR Modeling and Molecular Dynamics Simulation.
    Bavi R, Kumar R, Choi L, Woo Lee K.
    PLoS One; 2016 Mar 14; 11(1):e0147190. PubMed ID: 26784025
    [Abstract] [Full Text] [Related]

  • 4. Molecular Modeling Studies on Carbazole Carboxamide Based BTK Inhibitors Using Docking and Structure-Based 3D-QSAR.
    Li R, Du Y, Gao Z, Shen J.
    Int J Mol Sci; 2018 Apr 19; 19(4):. PubMed ID: 29671827
    [Abstract] [Full Text] [Related]

  • 5. In silico design of novel FAK inhibitors using integrated molecular docking, 3D-QSAR and molecular dynamics simulation studies.
    Shirvani P, Fassihi A.
    J Biomol Struct Dyn; 2022 Aug 19; 40(13):5965-5982. PubMed ID: 33475043
    [Abstract] [Full Text] [Related]

  • 6. QSAR analysis of nicotinamidic compounds and design of potential Bruton's tyrosine kinase (Btk) inhibitors.
    Santos-Garcia L, Assis LC, Silva DR, Ramalho TC, da Cunha EF.
    J Biomol Struct Dyn; 2016 Jul 19; 34(7):1421-40. PubMed ID: 26305710
    [Abstract] [Full Text] [Related]

  • 7. Molecular modelling studies on cinnoline-based BTK inhibitors using docking and structure-based 3D-QSAR.
    Li R, Du Y, Shen J.
    SAR QSAR Environ Res; 2018 Nov 19; 29(11):847-873. PubMed ID: 30280589
    [Abstract] [Full Text] [Related]

  • 8. Molecular modeling-driven approach for identification of Janus kinase 1 inhibitors through 3D-QSAR, docking and molecular dynamics simulations.
    Itteboina R, Ballu S, Sivan SK, Manga V.
    J Recept Signal Transduct Res; 2017 Oct 19; 37(5):453-469. PubMed ID: 28537140
    [Abstract] [Full Text] [Related]

  • 9. Structural optimization of pyrrolopyrimidine BTK inhibitors based on molecular simulation.
    Wu J, Li P, Chen X, Liu R, Mu Y, Shen Y, Cheng X, Shu M, Bai Y.
    J Mol Model; 2023 Nov 11; 29(12):367. PubMed ID: 37950076
    [Abstract] [Full Text] [Related]

  • 10. Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors.
    Balupuri A, Balasubramanian PK, Gadhe CG, Cho SJ.
    SAR QSAR Environ Res; 2014 Nov 11; 25(8):651-71. PubMed ID: 24911214
    [Abstract] [Full Text] [Related]

  • 11. Virtual screening and structure-activity relationship study of novel BTK inhibitors in Traditional Chinese Medicine for the treatment of rheumatoid arthritis.
    Sun L, Wang Z, Yang Z, Liu X, Dong H.
    J Biomol Struct Dyn; 2023 Nov 11; 41(24):15219-15233. PubMed ID: 36914235
    [Abstract] [Full Text] [Related]

  • 12. 3D-QSAR-aided design of potent c-Met inhibitors using molecular dynamics simulation and binding free energy calculation.
    Balasubramanian PK, Balupuri A, Bhujbal SP, Cho SJ.
    J Biomol Struct Dyn; 2019 May 11; 37(8):2165-2178. PubMed ID: 30044205
    [Abstract] [Full Text] [Related]

  • 13. Molecular modeling studies to characterize N-phenylpyrimidin-2-amine selectivity for CDK2 and CDK4 through 3D-QSAR and molecular dynamics simulations.
    Chohan TA, Chen JJ, Qian HY, Pan YL, Chen JZ.
    Mol Biosyst; 2016 Apr 11; 12(4):1250-68. PubMed ID: 26883408
    [Abstract] [Full Text] [Related]

  • 14. Molecular dynamics simulations reveal structural insights into inhibitor binding modes and mechanism of casein kinase II inhibitors.
    Ul-Haq Z, Ashraf S, Bkhaitan MM.
    J Biomol Struct Dyn; 2019 Mar 11; 37(5):1120-1135. PubMed ID: 29527958
    [Abstract] [Full Text] [Related]

  • 15. Molecular dynamics simulation, free energy calculation and structure-based 3D-QSAR studies of B-RAF kinase inhibitors.
    Yang Y, Qin J, Liu H, Yao X.
    J Chem Inf Model; 2011 Mar 28; 51(3):680-92. PubMed ID: 21338122
    [Abstract] [Full Text] [Related]

  • 16. 3D-QSAR and molecular docking study of LRRK2 kinase inhibitors by CoMFA and CoMSIA methods.
    Pourbasheer E, Aalizadeh R.
    SAR QSAR Environ Res; 2016 May 28; 27(5):385-407. PubMed ID: 27228480
    [Abstract] [Full Text] [Related]

  • 17. In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation.
    He Q, Han C, Li G, Guo H, Wang Y, Hu Y, Lin Z, Wang Y.
    Comput Biol Chem; 2020 Oct 28; 88():107328. PubMed ID: 32688011
    [Abstract] [Full Text] [Related]

  • 18. Molecular Modeling Studies of N-phenylpyrimidine-4-amine Derivatives for Inhibiting FMS-like Tyrosine Kinase-3.
    Ghosh S, Keretsu S, Cho SJ.
    Int J Mol Sci; 2021 Nov 19; 22(22):. PubMed ID: 34830393
    [Abstract] [Full Text] [Related]

  • 19. Molecular modeling study of CP-690550 derivatives as JAK3 kinase inhibitors through combined 3D-QSAR, molecular docking, and dynamics simulation techniques.
    Wang JL, Cheng LP, Wang TC, Deng W, Wu FH.
    J Mol Graph Model; 2017 Mar 19; 72():178-186. PubMed ID: 28107751
    [Abstract] [Full Text] [Related]

  • 20. Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods.
    Balupuri A, Balasubramanian PK, Cho SJ.
    Curr Comput Aided Drug Des; 2016 Mar 19; 12(4):302-313. PubMed ID: 27585602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.